BioCentury
ARTICLE | Company News

Immuron, Hadassah Medical Organization deal

April 27, 2009 7:00 AM UTC

Immuron (formerly Anadis Ltd.) will acquire Hadassah's IP covering an oral immune modulation technology. Immuron initially will use the technology with its dairy-derived antibody technology to develo...